JP2014516037A5 - - Google Patents

Download PDF

Info

Publication number
JP2014516037A5
JP2014516037A5 JP2014511554A JP2014511554A JP2014516037A5 JP 2014516037 A5 JP2014516037 A5 JP 2014516037A5 JP 2014511554 A JP2014511554 A JP 2014511554A JP 2014511554 A JP2014511554 A JP 2014511554A JP 2014516037 A5 JP2014516037 A5 JP 2014516037A5
Authority
JP
Japan
Prior art keywords
aib
exist
ac5c
ac4c
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014511554A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014516037A (ja
JP6284471B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/038434 external-priority patent/WO2012158965A2/en
Publication of JP2014516037A publication Critical patent/JP2014516037A/ja
Publication of JP2014516037A5 publication Critical patent/JP2014516037A5/ja
Application granted granted Critical
Publication of JP6284471B2 publication Critical patent/JP6284471B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014511554A 2011-05-18 2012-05-17 インスリン抵抗性のための改善されたペプチドの調合薬 Active JP6284471B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161487640P 2011-05-18 2011-05-18
US61/487,640 2011-05-18
US201161543716P 2011-10-05 2011-10-05
US61/543,716 2011-10-05
PCT/US2012/038434 WO2012158965A2 (en) 2011-05-18 2012-05-17 Improved peptide pharmaceuticals for insulin resistance

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017028560A Division JP6684396B2 (ja) 2011-05-18 2017-02-19 インスリン抵抗性のための改善されたペプチドの調合薬

Publications (3)

Publication Number Publication Date
JP2014516037A JP2014516037A (ja) 2014-07-07
JP2014516037A5 true JP2014516037A5 (https=) 2015-07-09
JP6284471B2 JP6284471B2 (ja) 2018-02-28

Family

ID=47177642

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2014511554A Active JP6284471B2 (ja) 2011-05-18 2012-05-17 インスリン抵抗性のための改善されたペプチドの調合薬
JP2017028560A Active JP6684396B2 (ja) 2011-05-18 2017-02-19 インスリン抵抗性のための改善されたペプチドの調合薬
JP2019192289A Active JP7015610B2 (ja) 2011-05-18 2019-10-21 インスリン抵抗性のための改善されたペプチドの調合薬
JP2022005872A Active JP7389150B2 (ja) 2011-05-18 2022-01-18 インスリン抵抗性のための改善されたペプチドの調合薬

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2017028560A Active JP6684396B2 (ja) 2011-05-18 2017-02-19 インスリン抵抗性のための改善されたペプチドの調合薬
JP2019192289A Active JP7015610B2 (ja) 2011-05-18 2019-10-21 インスリン抵抗性のための改善されたペプチドの調合薬
JP2022005872A Active JP7389150B2 (ja) 2011-05-18 2022-01-18 インスリン抵抗性のための改善されたペプチドの調合薬

Country Status (13)

Country Link
US (1) US10471127B2 (https=)
EP (1) EP2710031B9 (https=)
JP (4) JP6284471B2 (https=)
KR (5) KR102255479B1 (https=)
CN (2) CN103732617A (https=)
AU (1) AU2012255119B2 (https=)
BR (1) BR112013029409B1 (https=)
CA (2) CA3134906A1 (https=)
DK (1) DK2710031T3 (https=)
IL (1) IL229373B (https=)
MX (1) MX344219B (https=)
RU (1) RU2602801C2 (https=)
WO (1) WO2012158965A2 (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA95235C2 (en) 2005-05-04 2011-07-25 Зииланд Фарма А/С Glucagon-like-peptide-2 (glp-2) analogues
CN101573376B (zh) 2006-11-08 2013-11-06 西兰制药公司 选择性胰高血糖素样肽-2(glp-2)类似物
CN108892709A (zh) 2011-05-18 2018-11-27 欧莫德里斯制药公司 改良的肽药物
DK2710031T3 (en) * 2011-05-18 2018-01-02 Mederis Diabetes Llc IMPROVED PEPTID MEDICINALS FOR INSULIN RESISTANCE
AU2012311484B2 (en) 2011-09-23 2017-04-13 Novo Nordisk A/S Novel glucagon analogues
CN104540850B (zh) * 2012-05-03 2018-05-18 西兰制药公司 胰高血糖素样肽2(glp-2)类似物
UA116217C2 (uk) 2012-10-09 2018-02-26 Санофі Пептидна сполука як подвійний агоніст рецепторів glp1-1 та глюкагону
ES2906975T3 (es) 2012-11-20 2022-04-21 Eumederis Pharmaceuticals Inc Productos farmacéuticos de péptidos mejorados
MX360816B (es) * 2012-11-20 2018-11-15 Mederis Diabetes Llc Productos farmacéuticos peptídicos mejorados para la resistencia a la insulina.
AU2013366692B2 (en) 2012-12-21 2017-11-23 Sanofi Dual GLP1/GIP or trigonal GLP1/GIP/Glucagon agonists
EP2986313B1 (en) 2013-04-18 2019-06-12 Novo Nordisk A/S Stable, protracted glp-1/glucagon receptor co-agonists for medical use
EP3080154B1 (en) 2013-12-13 2018-02-07 Sanofi Dual glp-1/gip receptor agonists
EP3080152A1 (en) 2013-12-13 2016-10-19 Sanofi Non-acylated exendin-4 peptide analogues
WO2015086733A1 (en) 2013-12-13 2015-06-18 Sanofi Dual glp-1/glucagon receptor agonists
WO2015086728A1 (en) 2013-12-13 2015-06-18 Sanofi Exendin-4 peptide analogues as dual glp-1/gip receptor agonists
TW201625670A (zh) 2014-04-07 2016-07-16 賽諾菲公司 衍生自exendin-4之雙重glp-1/升糖素受體促效劑
TW201625669A (zh) 2014-04-07 2016-07-16 賽諾菲公司 衍生自艾塞那肽-4(Exendin-4)之肽類雙重GLP-1/升糖素受體促效劑
TW201625668A (zh) 2014-04-07 2016-07-16 賽諾菲公司 作為胜肽性雙重glp-1/昇糖素受體激動劑之艾塞那肽-4衍生物
PT3155017T (pt) * 2014-05-28 2024-05-14 Mederis Diabetes Llc Farmacêuticos peptídicos melhorados para resistência à insulina
US10570184B2 (en) 2014-06-04 2020-02-25 Novo Nordisk A/S GLP-1/glucagon receptor co-agonists for medical use
US9932381B2 (en) 2014-06-18 2018-04-03 Sanofi Exendin-4 derivatives as selective glucagon receptor agonists
PE20171154A1 (es) 2014-12-30 2017-08-16 Hanmi Pharm Ind Co Ltd Derivados de glucagon con estabilidad mejorada
EP3286245A4 (en) * 2015-04-21 2018-09-19 Ran Biotechnologies, Inc. Novel fluorinated surfactants
AR105319A1 (es) 2015-06-05 2017-09-27 Sanofi Sa Profármacos que comprenden un conjugado agonista dual de glp-1 / glucagón conector ácido hialurónico
WO2016198628A1 (en) 2015-06-12 2016-12-15 Sanofi Non-acylated exendin-4 derivatives as dual glp-1/glucagon receptor agonists
WO2016198624A1 (en) 2015-06-12 2016-12-15 Sanofi Exendin-4 derivatives as trigonal glp-1/glucagon/gip receptor agonists
EP4523705A3 (en) 2015-06-30 2025-06-11 Hanmi Pharm. Co., Ltd. Glucagon derivative and a composition comprising a long acting conjugate of the same
TW201706291A (zh) 2015-07-10 2017-02-16 賽諾菲公司 作為選擇性肽雙重glp-1/升糖素受體促效劑之新毒蜥外泌肽(exendin-4)衍生物
SG11201805586SA (en) 2015-12-31 2018-07-30 Hanmi Pharmaceutical Co Ltd Triple glucagon/glp-1/gip receptor agonist
EP3479841A4 (en) 2016-06-29 2020-03-04 Hanmi Pharm. Co., Ltd. GLUCAGON DERIVATIVE, CONJUGATE THEREOF, COMPOSITION THEREOF AND THERAPEUTIC USE THEREOF
EP3551651B1 (en) 2016-12-09 2024-03-06 Zealand Pharma A/S Acylated glp-1/glp-2 dual agonists
IL299864B2 (en) 2017-06-16 2024-06-01 Zealand Pharma As Dosage regimes for the administration of glucagon-like-peptide-2 (glp-2) analogues
CN108054388B (zh) * 2017-12-26 2020-02-21 吉林大学 以h6p2w18/l-3-(2-萘基)-丙氨酸复合水基黏合剂为电极涂层的化学电池
EP4506017A3 (en) * 2018-01-03 2025-05-14 Mederis Diabetes, LLC Improved peptide pharmaceuticals for treatment of nash and other disorders
CN117202924A (zh) 2020-12-07 2023-12-08 斯皮特弗尔制药有限责任公司 使用glp-1r和gcgr平衡激动剂降低血糖和/或体重的治疗方案和方法
US12281149B2 (en) 2021-05-13 2025-04-22 Carmot Therapeutics, Inc. Modulators of G-protein coupled receptors

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
JPS6023084B2 (ja) 1979-07-11 1985-06-05 味の素株式会社 代用血液
US4675189A (en) 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
US4640835A (en) 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
US4496689A (en) 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
EP0206448B1 (en) 1985-06-19 1990-11-14 Ajinomoto Co., Inc. Hemoglobin combined with a poly(alkylene oxide)
US4791192A (en) 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
US5661130A (en) 1993-06-24 1997-08-26 The Uab Research Foundation Absorption enhancers for drug administration
JPH1160598A (ja) 1997-08-15 1999-03-02 Asahi Glass Co Ltd オピオイド様ペプチド
US6924264B1 (en) * 1999-04-30 2005-08-02 Amylin Pharmaceuticals, Inc. Modified exendins and exendin agonists
US6309633B1 (en) * 1999-06-19 2001-10-30 Nobex Corporation Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
RU2181729C1 (ru) 2000-09-20 2002-04-27 Калюжин Олег Витальевич Производные мурамовой кислоты
US6858580B2 (en) 2001-06-04 2005-02-22 Nobex Corporation Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6835802B2 (en) 2001-06-04 2004-12-28 Nobex Corporation Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
US6864069B2 (en) * 2001-10-05 2005-03-08 Bayer Pharmaceuticals Corporation Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
ES2411007T3 (es) 2001-10-10 2013-07-04 Novo Nordisk A/S Remodelación y glicoconjugación de péptidos
US6881829B2 (en) 2002-04-26 2005-04-19 Chimeracom, L.L.C. Chimeric hybrid analgesics
US20060046962A1 (en) 2004-08-25 2006-03-02 Aegis Therapeutics Llc Absorption enhancers for drug administration
US20110257096A1 (en) 2004-08-25 2011-10-20 Aegis Therapeutics, Inc. Compositions for drug administration
ITRM20040607A1 (it) 2004-12-15 2005-03-15 Biogen S R L Analoghi della dermorfina ad attivita' analgesica.
US7776819B2 (en) 2005-03-03 2010-08-17 The Board Of Trustees Of The University Of Illinois Targeted drug delivery of pain and addiction therapies using opioid receptor-mediated internalization
CA2607566A1 (en) 2005-05-06 2006-11-16 Bayer Pharmaceuticals Corporation Glucagon-like peptide 1 (glp-1) receptor agonists and their pharmacological methods of use
US7390788B2 (en) 2005-06-23 2008-06-24 Pert Candace B Peptide pharmaceutical compositions
WO2007060692A2 (en) 2005-11-24 2007-05-31 Brain N' Beyond Biotech Pvt. Ltd. Compositions for increasing bioavailability of peptides or proteins and method thereof
US8173594B2 (en) 2006-06-23 2012-05-08 Aegis Therapeutics, Llc Stabilizing alkylglycoside compositions and methods thereof
US7998927B2 (en) 2006-06-23 2011-08-16 Aegis Therapeutics, Llc Stabilizing alkylglycoside compositions and methods thereof
ES2655734T3 (es) * 2006-10-04 2018-02-21 Novo Nordisk A/S Glicopéptidos y azúcares pegilados unidos a glicerol
AR072160A1 (es) * 2008-06-17 2010-08-11 Univ Indiana Res & Tech Corp Co-agonistas del receptor de glucagon/glp-1
US8221753B2 (en) 2009-09-30 2012-07-17 Tracon Pharmaceuticals, Inc. Endoglin antibodies
DK2710031T3 (en) 2011-05-18 2018-01-02 Mederis Diabetes Llc IMPROVED PEPTID MEDICINALS FOR INSULIN RESISTANCE
CN108892709A (zh) 2011-05-18 2018-11-27 欧莫德里斯制药公司 改良的肽药物
MX360816B (es) * 2012-11-20 2018-11-15 Mederis Diabetes Llc Productos farmacéuticos peptídicos mejorados para la resistencia a la insulina.
ES2906975T3 (es) 2012-11-20 2022-04-21 Eumederis Pharmaceuticals Inc Productos farmacéuticos de péptidos mejorados
PT3155017T (pt) 2014-05-28 2024-05-14 Mederis Diabetes Llc Farmacêuticos peptídicos melhorados para resistência à insulina

Similar Documents

Publication Publication Date Title
JP2014516037A5 (https=)
JP2016501204A5 (https=)
JP2020073481A5 (https=)
RU2013154047A (ru) Пептидные лекарственные препараты с повышенной эффективностью против инсулинорезистентности
JP2020143066A5 (https=)
JP2014516036A5 (https=)
JP2012067099A5 (https=)
JP2017535527A5 (https=)
JP2011524420A5 (https=)
JP7796636B2 (ja) ヒトトランスフェリンレセプター結合ペプチド
EP4199946B1 (en) Crf2 receptor agonists and their use in therapy
JP2011524418A5 (https=)
JPH08510261A (ja) ポリマーを用いたビタミンb▲下1▼▲下2▼吸収系の増幅
AU2010216372A1 (en) Cytotoxic conjugates having neuropeptide Y receptor binding compound
CZ168893A3 (en) Novel amylin-antagonizing peptides and their use
JPH0219397A (ja) アルギニンバソプレシン拮抗剤の新規線形誘導体類
WO2024022465A1 (zh) 一种人胰淀素多肽衍生物及其用途
CN101302246B (zh) 黑色素皮质激素受体七肽类激动剂及其制备方法和用途
JPH0338600A (ja) Vip同族体
US9821072B2 (en) Activated neurotensin molecules and the uses thereof
US6316414B1 (en) Somatostatin analogs for the treatment of cancer
CN109069577A (zh) Hiv进入的d-肽抑制剂以及使用方法
WO2001062777A1 (en) Bombesin analogs for treatment of cancer
CN107592865B (zh) 中和流感病毒的拟肽化合物
CN102250251A (zh) 一种脑啡肽类似物的聚乙二醇化衍生物